Percutaneous Aspiration, Lavage and Antibiotic Instillation. New Approach in the Management of Acute Calculous Cholecystitis by Salim, Aws S.
HPB Surgery, 1991, Vol. 3, pp. 167-176
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1991 Harwood Academic Publishers GmbH
Printed in the United Kingdom
PERCUTANEOUS ASPIRATION, LAVAGE AND
ANTIBIOTIC INSTILLATION. NEW APPROACH IN
THE MANAGEMENT OF ACUTE CALCULOUS
CHOLECYSTITIS
AWS S. SALIM
University Department of Surgery at the Medical City in Baghdad, Iraq
(Received 5 March 1990, in final form 7 May 1990)
Distension of the gallbladder and bacterial infection can perpetuate an attack of acute calculous
cholecystitis and produce its local and systemic complications. This prospective randomized trial was
conducted on patients with their first episode of acute calculous cholecystitis which was associated with
pyrexia and tachycardia to examine whether ultrasound guided percutaneous aspiration and lavage of
the gallbladder followed by intra-lumenal instillation of 500 mg ampicillin (PALA) enhanced recovery
from cholecystitis. Twenty patients were randomized to receive 500 mg of ampicillin every 6 hours for 5
days and another 20 patients were randomized to receive this treatment in addition to PALA within 12
hours of admission. Twenty four hours after admission to hospital, all the patients treated with PALA
were apyrexial and had no residual right hypochondrial tenderness or guarding, a result superior (p<
0.001) to that of the group without PALA where at least 75% of patients were still showing these signs.
Two days after admission the WBC count of the PALA group was significantly (p< 0.05) lower than
that of the other group (6.32 + 0.1 109/L vs 10.31 + 0.4 109/L, mean + SEM, n 20). Four days
after admission, all members of the PALA group were comfortably tolerating solid food for the previous
24 hours and were, therefore, discharged home whereas all members of the other group were still in
hospital and 85% of them were discharged home after hospitalization for 6 to 7 days. Three members
(15%) of this group deteriorated and underwent emergency surgery.
The results show that addition of PALA to the conventional non-operative treatment of acute
cholecystitis enhances recovery and avoids the complications necessitating emergency surgery.
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INTRODUCTION
Although there is no dispute that in an otherwise healthy subject cholecystectomy
is a safe procedure for the treatment of symptomatic gallstones, the timing of this
operation remains controversial1-4. Acute cholecystitis is the most frequent compli-
cation of gallstones and may progress to a mucocele, "empyema", perforation,
gangrene, fistula formation or ascending cholangitis5-7. Consequently, emergency
surgery may be necessary for some cases, however, its mortality and morbidity
rates continue to be higher than those of elective surgery3’4.
From the pathological features and natural history of acute cholecystitis it can be
reasoned that most attacks will remit, thus enabling emergency surgery to be
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avoided3-7. It follows that any measures aimed at improving the outcome of
non-operative management of acute cholecystitis may play a positive role in
reducing the risks of this disorder. Infection and increased tension within the
gallbladder causing a diminished vascular supply are the major factors responsible
for producing the complications that can be associated with an attack of acute
cholecystitis. Theoretically, the antibiotic attaining the highest concentration in the
biliary tree and being most active against the commonest organisms infecting it
would be chosen for conservative treatment of cholecystitis6. Much has been
written on the concentration which various antibiotics can attain in the biliary
system8, but if there is a blockage of the cystic or the common bile ducts with
superadded infection, this property becomes of doubtful value6. The present study
was, therefore designed to determine whether percutaneous aspiration of the
gallbladder followed by lavage and instillation of an antibiotic improves the
outcome of conservative treatment of acute cholecystitis.
PATIENTS AND METHODS
Patients
This is a prospective randomized trial conducted on patients with their first attack
of acute calculous cholecystitis which was associated with pyrexia and tachycardia.
Randomization was by drawing sealed envelopes. Treatment started immediately
after the diagnosis was made.
Patients judged suitable for this study were those presenting with clinical signs
and symptoms (including a positive Murphy’s sign) of acute cholecystitis coupled
with pyrexia (more than 38C), tachycardia, leucocytosis, normal serum amylase
levels and liver function tests, and ultrasonic evidence of a distended gallbladder
containing one or more stones.
Exclusion Criteria
Patients were not recruited into the study if there was evidence of one or more of
the following: septic shock, jaundice, diabetes, pregnancy, alcoholism, sensitivity
to penicillins, hepatic or renal disorders, serious underlying disease- for example
cardiorespiratory problems, or other gastrointestinal disorders like reflux oesopha-
gitis, hiatus herniation, peptic ulceration, the Zollinger-Ellison syndrome, Crohn’s
disease, ulcerative colitis, or irritable bowel syndrome. These conditions would
make it difficult to assess the significance of the patient’s signs and symptoms.
History of biliary disease, previous gastrointestinal surgery, or concomitant treat-
ment with any medication made the patient unsuitable for this study. In addition,
patients were not studied if ultrasonically the gallbladder was not distended or
contained no stones and if there was any suggestion of choledocholithiasis or
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The Study Design
Acute cholecystitis was initially diagnosed from the history and physical examin-
ation. Patients were then completely fasted, given 50 mg of pethidine by intramus-
cular injection and admitted to hospital for bed rest and further management. In all
cases radiological examination with plain abdominal films was undertaken to
exclude visceral perforation. Standard haematology and biochemistry measure-
ments (haemoglobin, erythrocyte sedimentation rate, packed cell volume, white
blood cell count (WBC), electrolytes, urea, creatinine, urate, liver function tests)
and urine examination were carried out.
After admission to hospital, patients were confined to bed until they were
apyrexial and hydrated intraveneously. They were allowed nil orally for 24 hours
then sips of water every hour for 12 hours followed by another 12 hours of no more
than 100 mls of water every hour. If these volumes were well tolerated, the
intravenous line was disconnected at the end of the last 12 hours and patients were
allowed free fluid intake by mouth and gradually reintroduced to solid food. The
intravenous maintenance fluids for hydration were one litre of dextrose-saline with
20 mmol potassium every 8 hours. Analgesia was provided by intramuscular
pethidine (not exceeding 50 mg every 4 hours). In all cases, ampicillin B.P.
(Penbritin, Beecham Laboratories, Brentford, U.K.), 500 mg every 6 hours, was
given by intramuscular injection for 48 hours then, if possible, orally for 3 days (5
days of antibiotic treatment). Within 12 hours of admission patients were examined
ultrasonically and once this scan confirmed the diagnosis of acute calculous
cholecystitis, they were randomized to have ultrasound-guided percutaneous aspi-
ration of the gallbladder with lavage and instillation of ampicillin or to remain on
their current therapeutic regimen. The percutaneous procedure was performed
under ultrasound guidance as follows: with the patient in the left lateral position, a
skin port of entry that enabled the gallbladder to be punctured directly was chosen
just below the right ninth costal cartilage and the site was infiltrated with 2-3 ml of
local anaesthetic (1% plain xylocaine). A long 20-guage needle (Cook Inc.,
Bloomington, Indiana, USA) was advanced directly into the lumen of the gallblad-
der via the fundus and its contents were aspirated until it was no longer distended
ultrasonically. The aspirate was sent for a Gram stain and bacteriological culture
(both aerobic and anaerobic). Five ml of double distilled water were instilled into
the gallbladder and the same volume aspirated and discarded. This lavage was
repeated then 500 mg of ampicillin powder in 5 ml double distilled water were
instilled into the gallbladder. The needle was withdrawn and a small dressing
applied over its port of entry.
The diagnostic ultrasonography was repeated 48 hours later to re-examine the
size of the gallbladder. The WBC count was determined on each of the first three
days after admission.
Progress was assessed by following the physical signs and symptoms (pain, fever,
tenderness, guarding), theWBC count, the ultrasonic image of the gallbladder, and
the return to and tolerance of solid food.
After recovery from the attack (that is, when all the signs and symptoms of acute
cholecystitis had ceased, theWBC count had returned to normal and solid food had
been tolerated without complications for at least 24 hours) patients were discharged170 A.S. SALIM
home to be re-admitted for an elective cholecystectomy as soon as time was
available on a routine operating list.
The end points of this study were successful recovery from the acute attack or
failure of either of the non-operative policies employed.
Ethical Considerations
This study was approved by the Ethical Committee of Human Experimentation of
the hospital and every patient gave written informed consent.
Statistical Analysis
Results are expressed as the mean + SEM unless stated otherwise. The Wilcoxon’s
signed-ranks test for paired non-parametric data was used to determine the
statistical significance (p< 0.05) of observed differences within each group and the
Mann-Whitney U test for non-parametric data or the X2 test with Yates’ correction
were used for comparisons between groups.
RESULTS
The patients studied and treatment results are presented in Tables I, II.
Patient Characteristics
Twenty patients were randomized to each of the study groups and their age and sex
characteristics were well matched (Table 1).
Table 1 Patient Characteristics
Percutaneous No percutaneous
treatment treatment
n 20 20
Age
mean year 29 33
range 23-47 27-51
Women (n) 15 16
Men (n) 5 4
General Observations
The duration of symptoms before admission to hospital was less than 24 hours in
every member of the study groups. In the group treated percutaneously, 3 men and
5 women were smokers, and in the group without this treatment, 2 men and 4
women, were smokers. In the latter group, all the men (n 4) and 2 women were
social drinkers and in the group treated percutaneously, 4 men and 3 women were
social drinkers. Three women in each group were nulliparous and all the women in
the study had at some stage in their life used the contraceptive pill. At the time of
admission, 5 women in the group treated percutaneously and 7 women in the otherLAVAGE IN CHOLECYSTITIS 171
group were on this pill. None of the patients studied were hyperlipaemic or
hypercholesterolaemic. Nine patients (45%) in the group treated percutaneously
and 7 patients (35%) in the other group had a family history of gallstones.
Ultrasonically, 5 patients in the group treated conventionally and 7 patients in
the group treated percutaneously had solitary gallbladder calculi, which in 2
members of each group appeared to be larger than one cm in diameter, while all the
remaining patients had multiple calculi.
The Percutaneous Procedure
In all cases this procedure was very well tolerated and produced no pain or
discomfort. None of the patients developed infection at the site of needle entry and
the repeat ultrasound scan showed no evidence of right hypochondrial collection
(gallbladder leakage) in any case.
Comparison between the Groups (Table 2)
The percutaneous treatment enhanced recovery from the acute attack and pre-
vented patient deterioration. Soon after this treatment and within 12 hours of
admission, 85% of the patients were relieved of their right hypochondrial pain and
none had this pain 24 hours after admission. At corresponding time periods, the
number of patients without this treatment who had pain was significantly (p<
0.001) higher and 48 hours after admission 15% of them were still having pain. It
follows that the duration of analgesic treatment was significantly (p< 0.001)
reduced by the percutaneous procedure. This procedure was within 12 hours after
admission more effective than expectant treatment alone (p< 0.01) in reducing the
number of patients having fever, tachycardia, a positive Murphy’s sign, and right
hypochondrial tenderness with or without guarding or rigidity. By 24 hours after
admission, this effectiveness was further increased and none of the patients
remained with any of these signs compared with at least 75% of patients given
expectant treatment alone, (p< 0.001). Even 48 hours after admission, at least
20% of patients in the latter group were still symptomatic. The percutaneous
procedure was more effective than traditional expectant treatment in controlling
the magnitude of the inflammatory process produced by acute cholecystitis. At
each of 24 and 48 hours after admission, the WBC count was significantly (p<
0.05) less than the previous 24 hours’ count and by the second day after admission
this count was significantly (p< 0.05) less than that of the group treated traditio-
nally.
Although at diagnostic ultrasonography all gallbladders were distended, a
further scan 48 hours after admission showed that none treated percutaneously
remained distended compared with 20% of cases in the other group which
remained distended. Bacteriological examination of the bile aspirated percuta-
neously showed no growth in 8 cases (40%) whilst the remaining cases predomi-
nantly grew one of Escherichia coli (40%), Klebsiella pneumoniae (15%) or
Streptococcus faecalis (5%).
All the patients treated percutaneously comfortably tolerated free fluids by
mouth 48 hours after admission to hospital and, therefore, their intravenous lines
were disconnected making them freely mobile and unrestricted. Such progress was
only obse,rved in 60% of the patients in the other group (p < 0.01). Similarly, 72172 A.S. SALIM
Table 2 Treatment of Acute Cholecystitis
Percutaneous No percutaneous
treatment treatment
Fever/tachycardia (n)
on admission
after 12 hrs
after 24 hrs
after 48 hrs
Rt hypochondrial pain (n)
on admission
after 12 hrs
after 24 hrs
after 48 hrs
+ ve Murphy’s sign (n)
on admission
after 12 hrs
after 24 hrs
after 48hrs
20 (100% 20 (100%)
12 (60%) 20 (100%)
0 17(85%)
6(30%)
20 (100%) 20 (100%)
3(15%) 16(80%)
0 9(45%)
3(15%)
20(100%) 20(100%)
4 (20%) 20 (100%)
0 15(75%)
4 (20%)
WBC x 109/L)--mean
on admission 16.12 +0.3 14.11 +0.5
after 24 hrs 11.22 + 0.2 13.21 + 0.6
after 48 hrs 6.32+0.1 10.31 +0.4
after 72 hrs 5.47 +0.2 6.11 +0.5
Ultrasonically distended gallbladder (n)
48 hrs after admission
Patients deteriorating (n)
Patients tolerating free
fluids by mouth 48 hrs
after admission (n)
Patients tolerating solid food
72 hrs after admission (n)
0 4 (20%)
0 3 (5%)
20 (100%) 12 (60%)
20 (100%) 11 (55%)
Hospital stay (n)
4 days 20 (100%)
6 days 14 (70%)
7 days 3 (15%)
longer 3 (15%)
hours after admission, the number of patients in the latter group who were able to
tolerate solid food for 24 hours was significantly (p< 0.01) less than that of the
percutaneous group (100%). Consequently, all patients in this group were dis-
charged home by the fourth day after admission while all the patients in the other
group were still in hospital at this time period.
Three patients (15%) in the group treated conventionally did not respond to
treatment and began to deteriorate. Therefore, 48 to 72 hours after admission they
had emergency surgery during which no stones were found beyond the gallbladder.
All the patients who made a complete recovery from their acute attack remained
well, without any complaints of digestive disturbances, biliary colics or attacks ofLAVAGE IN CHOLECYSTITIS 173
fever, until they had an elective cholecystectomy some 6 weeks after they were
discharged from hospital. During this operation, 2 patients in each of the study
groups had stones in the common bile duct (missed by the earlier ultrasound scan).
DISCUSSION
Acute cholecystitis is produced by obstruction of the cystic duct. The gallbladder
wall becomes inflamed due to the irritation by the concentrated bile within it
producing a chemical cholecystitis, but bacterial infection soon supervenes5’6’7. In
most patients the condition will subside. However, in some cases there is the
possibility of increased tension causing a diminished vascular supply which, in turn,
leads to tension gangrene and perforation beginning at the fundus3’4. Short of this
event, a gallbladder full of pus causes continued local and systemic disturbance3’4. It
follows that reducing the tension within the gallbladder and eradicating infection
should be the top priorities of non-operative management of acute cholecystitis. It
is customary for this management to include an antibiotic when there is evidence
that bacterial infection is important (high fever, local tenderness), however,
obstruction of the biliary tree impairs its delivery into the lumen. Therefore, to
enable successful treatment of acute cholecystitis and to avoid its complications, the
present study introduced ultrasound guided percutaneous aspiration of the gallb-
ladder followed by lavage and direct instillation of an antibiotic into its lumen. This
procedure enhanced control of the inflammatory process produced by the acute
cholecystitis, thus enabling patients to recover from the attack and to be discharged
home after a significintly shorter time period than that after conventional treat-
ment alone (Table 2). More importantly, the percutaneous procedure prevented
failure of conventional treatment and the necessity of emergency surgery (Table 2).
Because an acute attack of cholecystitis may not resolve and may produce local
and systemic complications, some advocate cholecystectomy as the sole
management3’4’6. However, the morbidity and mortality of this approach remain
higher than those of elective cholecystectomy3’4. Furthermore, a high level of
expertise is required by the surgeon and there remains a group of patients who are
at risk of developing wound sepsis, such as those over 50 years of age, those with
jaundice, the obese and those who have been shown to have a non-functioning
gallbladder4’5. If emergency surgery is not the favoured policy for the management
of an acute attack and these cases are treated conservatively then the ones that fail
to respond or develop complications should undergo the safer option of
cholecystostomy3, this last procedure is still emergency surgery which carries the
risk of wound sepsis and demands longer hospital stay with all its implications on
cost and manpower. Considering these pros and cons, the best management policy
for acute cholecystitis would be to treat the attacks conservatively and to perform
elective surgery at a later day, preferably within a few weeks after the acute attack
has subsided. Addition of the percutaneous procedure presented in the present
study would ensure success of this policy. It might be argued, however, that the
procedure is invasive and may increase management costs. Such an argument
cannot be sustained in view of the following observations. First, no adverse events
were incurred by the percutaneous method and in particular it produced no
discomfort, pain, sepsis or leakage. Second, the hospital stay of the patients treated
percutaneously was less than that of those treated conventionally. Third, none of174 A.S. SALIM
the percutaneous cases succumbed to the acute attack whereas 15% of the patients
treated conventionally deteriorated and required emergency surgery. The success
of the percutaneous procedure did not appear to be dependent on the number or
size of calculi in the gallbladder, since these stone characteristics were roughly
similar between the two study groups.
The use of ampicillin for the present study might be criticised. This antibiotic is a
broad spectrum one which is active against the organisms commonly implicated in
acute cholecystitis, it is well excreted in the bile even when the biliary tree is
obstructed, and can be given orally or parenterally6. For these reasons it was
employed in the present investigation, however, the use of antibiotic combinations
might be even better in terms of the effectiveness in controlling the infection
produced by cholecystitis. This last point would be particularly true if such
combinations were to include an antibiotic effective against anaerobic organisms.
The percutaneous procedure was carried out using a needle. A significant
advantage can be attained if after the needle has punctured the gallbladder, a
plastic cannula was advanced into the gallbladder lumen and the needle removed.
This would enable placement of the cannula deep into the gallbladder and complete
evacuation of its contents without the fear of slipping out, thus achieving a more
complete removal of septic material from the gallbladder and perhaps enabling any
stone obstructing its outlet to slip back into the lumen. Furthermore, the volume of
the material recovered can give an estimate of the best volume of distilled water for
lavaging the gallbladder without causing distension.
In conclusion, this is the first report demonstrating that ultrasound guided
aspiration of the gallbladder followed by lavage and direct instillation of an
antibiotic into its lumen enhances control of acute attacks of cholecystitis afforded
by conventional conservative management.
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INVITED COMMENTARY:
We commend Dr. Salim for a very interesting and well-performed study. Clearly
these data demonstrate that percutaneous gallbladder evacuation with antibiotic
instillation is superior to parenteral antibiotics alone for the nonoperative treat-
ment of acute cholecystitis. Realistically, at this time we cannot advocate perform-
ing percutaneous gallbladder lavage and antibiotic instillation on all patients
presenting with acute cholecystitis for two reasons: 1. The treatment involves an
invasive procedure which, though well tolerated in the present study, will be
associated with some degree of technical complications and morbidity. 2. The
authors are recommending that this procedure be performed in a group of patients
in which noninvasive therapy, parenteral antibiotics alone, will be successful for
most. More appropriately, percutaneous gallbladder lavage and antibiotic instilla-
tion should be reserved for patients presenting with uncomplicated acute cholecys-
titis who fail to show improvement with 12 to 24 hours of parenteral antibiotics.
More importantly, these data lend further impetus to the developing field of
nonoperative therapy for calculus disease of the gallbladder. There is a growing
body of literature demonstrating the success of biliary lithotripsy in combination
with oral bile acid therapy for the treatment of cholelithiasis. However, with the
current clinical restrictions, only approximately 30% of patients presenting with
cholelithiasis will be eligible for this treatment. In addition, early studies with
biliary lithotripsy and oral bile acid therapy have suggested a 10% per year
recurrence rate. For these reasons, other treatment modalities must be developed if
nonoperative therapy of calculus disease of the gallbladder is to become a reality.
As Dr. Salim has mentioned in his discussion, percutaneous cholecystostomy is one
such important treatment modality. As of 1989, only 231 cases of percutaneous
cholecystostomy had been reported in the English language literature. These
studies generally were comprised of patients with advanced systemic illnesses, such
as malignancy, severe cardiorespiratory disease, and sepsis with organ failure.
Following percutaneous cholecystostomy, symptoms of cholecystitis improved or
resolved in approximately 90% of these high-risk patients within 24-48 hours.
Furthermore, when these patients stabilized, many were then able to tolerate
definitive cholecystectomy or simply had their drains removed without recurrent
symptoms. The overall complication rate cited in the literature is 8%, and there
have been only 2 deaths attributed to the procedure. Therefore, percutaneous
cholecystostomy appears to be a relatively safe and effective alternative in the
treatment of cholecystitis. In addition, percutaneous cholecystostomy also provides
a portal by which gallbladder calculi can be extracted, dissolved, and/or frag-
mented. Currently, the most promising gallstone solvent under development is176 A.S. SALIM
methyl-tert-butyl-ether (MTBE). In animal models and a few selected patients,
percutaneous cholecystostomy coupled with MTBE infusion has been effective in
dissolving cholesterol gallstones. The further development of percutaneous chole-
cystostomy and gallstone dissolution is critical since all patients with radiolucent
gallstones will be eligible for this therapy, regardless of the number and size of their
stones. However, as with lithotripsy, gallstone dissolution leaves the gallbladder in
situ and therefore is associated with a risk of recurrent stone formation. To combat
this problem, there have been experimental attempts at percutaneous gallbladder
ablation. Through a percutaneous cholecystostomy tube, the cystic duct is occluded
by a balloon catheter or plugged with a substance such as cyanoacryli-
nitrocellulose. Following this, a noxious agent such as absolute ethanol is instilled
into the gallbladder resulting in mucosal necrosis and mural fibrosis.
We believe the future of gallstone therapy will involve nonoperative percuta-
neous procedures such as those we have just described. The data provided by Dr.
Salim clearly illustrate that percutaneous evacuation of the gallbladder in the
setting of acute cholecystitis, results in a rapid resolution of the inflammatory
process. We envisage the day when percutaneous cholecystostomy with stone
extraction or dissolution, followed by gallbladder ablation, will be the procedure of
choice for the treatment of calculus disease of the gallbladder.
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